It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
British drug maker GlaxoSmithKline is seeking regulatory approval for the world's first malaria vaccine after trial data showed that it had cut the number of cases in African children.
Experts say that they are optimistic about the possibility of the world's first vaccine after the trial results.
Malaria, a mosquito-borne parasitic disease, kills hundreds of thousands of people worldwide every year.
Source: World Health Organization
About 3.3 billion people – half of the world's population – are at risk of malaria. In 2010, there were about 219 million malaria cases (with an uncertainty range of 154 million to 289 million) and an estimated 660 000 malaria deaths (with an uncertainty range of 490 000 to 836 000). Increased prevention and control measures have led to a reduction in malaria mortality rates by more than 25% globally since 2000 and by 33% in the WHO African Region.
like i say just playing devils advocate but its a interesting thought, what might fix one problem might just cause more down the line unless we can also develop a vaccine for poverty and hunger.
Then i suggest removing safety labels and signs, why must only the poor needs to die to control population? morons deserve it too.